Ascent Therapeutics
Ascent Therapeutics is pioneering a new class of drugs called pepducins. Pepducins are a breakthrough approach to targeting G-protein coupled receptors (GPCRs) on the inside surface of the cell membrane, dramatically expanding the GPCR frontier....Homepage: http://www.ascentrx.com
Total money raised: $8M
02142
67 Rogers Street
Cambridge
USA MA
Cambridge
USA MA
Phone: 617-715-1999
Updated on Mar 15, 2010
Ascent Therapeutics at CrunchBase
Ascent Therapeutics at CrunchBase
November, 2007
Ascent Therapeutics raised $8M in a Series A round from HealthCare Ventures, Novartis Bioventures, and TVM Capital
Ascent Therapeutics Secures $8 Million Series A 
venturedeal.com